Sunday, October 25, 2020 9:00:01 PM
Something is wonky about this info. On the site it says SamiVIR in the title and then proceeds to say SamiAIR is been approved when it has not gone through trials even.
So perhaps wishful thinking before the mid mid November deadline to nominate and meant SamiVIR or it's just nothing as anyone can nominate.
I don't know.
So perhaps wishful thinking before the mid mid November deadline to nominate and meant SamiVIR or it's just nothing as anyone can nominate.
I don't know.
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
